Company Description
Adamas Trust (NASDAQ: ADAMI) is a publicly traded company in the Real Estate Investment Trusts sector.
ADAMI stock has declined 0.2% over the past year. Shares last traded at $25.06.
On a trailing twelve-month basis, Adamas Trust reported revenue of $601.9M with net income of $149.0M and diluted earnings per share of $1.10. The company operates at a net profit margin of 24.8%.
This page provides a comprehensive overview of ADAMI stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Adamas Trust (ADAMI) stock last traded at $25.06, down 0.16% from the previous close. Over the past 12 months, the stock has lost 0.2%.
ADAMI Rankings
Latest News
SEC Filings
Adamas Trust has filed 5 recent SEC filings, including 5 Form 4. The most recent filing was submitted on June 23, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ADAMI SEC filings →
Financial Highlights
Adamas Trust generated $601.9M in revenue over the trailing twelve months, operating income reached $137.8M (22.9% operating margin), and net income was $149.0M, reflecting a 24.8% net profit margin. Diluted earnings per share stood at $1.10. The company generated $134.0M in operating cash flow.
Upcoming Events
Short Interest History
Short interest in Adamas Trust (ADAMI) currently stands at 85 shares, down 94.6% from the previous reporting period, representing 0.0% of the shares outstanding. Over the past 12 months, short interest has decreased by 92.1%.
Days to Cover History
Days to cover for Adamas Trust (ADAMI) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.5 days.
ADAMI Company Profile & Sector Positioning
Adamas Trust (ADAMI) operates in the Real Estate Investment Trusts sector and is listed on the NASDAQ.